<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Reported-in-House" bill-type="olc" dms-id="H13F5068F503B4D80ADB3997EB6F66230" key="H" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>116 HR 3153 RH: Expanding Findings for Federal Opioid Research and Treatment Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2019-06-06</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">IB</distribution-code>
		<calendar display="yes">Union Calendar No. 95</calendar>
		<congress display="yes">116th CONGRESS</congress><session display="yes">1st Session</session>
		<legis-num display="yes">H. R. 3153</legis-num>
		<associated-doc display="yes" role="report">[Report No. 116–131]</associated-doc>
		<current-chamber display="yes">IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action display="yes">
			<action-date date="20190606">June 6, 2019</action-date>
			<action-desc><sponsor name-id="W000825">Ms. Wexton</sponsor> (for herself, <cosponsor name-id="B001307">Mr. Baird</cosponsor>, <cosponsor name-id="D000631">Ms. Dean</cosponsor>, <cosponsor name-id="C001078">Mr. Connolly</cosponsor>, <cosponsor name-id="F000466">Mr. Fitzpatrick</cosponsor>, and <cosponsor name-id="K000381">Mr. Kilmer</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HSY00">Committee on Science, Space, and Technology</committee-name></action-desc>
		</action>
		<action>
			<action-date>June 27, 2019</action-date>
			<action-desc>Additional sponsors: <cosponsor name-id="W000800">Mr. Welch</cosponsor>, <cosponsor name-id="B001306">Mr. Balderson</cosponsor>, <cosponsor name-id="C001090">Mr. Cartwright</cosponsor>, <cosponsor name-id="M000312">Mr. McGovern</cosponsor>, <cosponsor name-id="W000814">Mr. Weber of Texas</cosponsor>, <cosponsor name-id="R000616">Mr. Rouda</cosponsor>, <cosponsor name-id="S001215">Ms. Stevens</cosponsor>, <cosponsor name-id="G000588">Mr. Gonzalez of Ohio</cosponsor>, <cosponsor name-id="G000582">Miss González-Colón of Puerto Rico</cosponsor>, <cosponsor name-id="T000483">Mr. Trone</cosponsor>, <cosponsor name-id="L000563">Mr. Lipinski</cosponsor>, <cosponsor name-id="M001198">Mr. Marshall</cosponsor>, <cosponsor name-id="C001117">Mr. Casten of Illinois</cosponsor>, <cosponsor name-id="H001083">Ms. Kendra S. Horn of Oklahoma</cosponsor>, <cosponsor name-id="B001291">Mr. Babin</cosponsor>, <cosponsor name-id="J000126">Ms. Johnson of Texas</cosponsor>, <cosponsor name-id="L000491">Mr. Lucas</cosponsor>, <cosponsor name-id="S001207">Ms. Sherrill</cosponsor>, <cosponsor name-id="B001278">Ms. Bonamici</cosponsor>, and <cosponsor name-id="C001080">Ms. Judy Chu of California</cosponsor>
			</action-desc>
		</action>
		<action><action-date>June 27, 2019</action-date><action-desc>Committed to the Committee of the Whole House on the State of the Union and ordered to be printed<pagebreak></pagebreak></action-desc></action><legis-type>A BILL</legis-type>
		<official-title display="yes">To direct the Director of the National Science Foundation to support research on opioid addiction,
			 and for other purposes.<pagebreak></pagebreak></official-title>
	</form>
	<legis-body id="HD2188BCB94E04991901C60122C9400A8" style="OLC">
		<section id="H74155FBEF8504219897A999B3649FCAF" section-type="section-one"><enum>1.</enum><header>Short title; findings</header>
 <subsection id="H93C580B1015A4A93B49867334D83EE3B"><enum>(a)</enum><header>Short title</header><text display-inline="yes-display-inline">This Act may be cited as the <quote><short-title>Expanding Findings for Federal Opioid Research and Treatment Act</short-title></quote> or the <quote><short-title>EFFORT Act</short-title></quote>.</text> </subsection><subsection id="H31E1F489D2BC429F901C65BF28597744"><enum>(b)</enum><header>Findings</header><text>The Congress finds that—</text>
 <paragraph id="HC93036AC74D240939BC5CE49FCBFE682"><enum>(1)</enum><text display-inline="yes-display-inline">research gaps currently exist in the prevention and treatment of opioid addiction;</text> </paragraph><paragraph id="H7552AB51DA4D4F5492A3873B1FAFD496"><enum>(2)</enum><text display-inline="yes-display-inline">the National Science Foundation’s research on opioid addiction has increased understanding of the neuroscience of addiction, substance abuse intervention, the role of illicit supply networks, the secondary effects on families, the use of technology to address the opioid epidemic, and options for alternative, non-addictive therapeutics for pain; and</text>
 </paragraph><paragraph id="HB4568F012AEA46B6877AD62DD994DB7D"><enum>(3)</enum><text>the National Science Foundation and the National Institutes of Health have recognized that fundamental questions in basic, clinical, and translational research would benefit greatly from multidisciplinary approaches and collaboration.</text>
				</paragraph></subsection></section><section id="H9735136F671C4C1991352FC6F907EF8E"><enum>2.</enum><header>NSF support of research on opioid addiction</header>
 <text display-inline="no-display-inline">The Director of the National Science Foundation, in consultation with the Director of the National Institutes of Health, shall support merit-reviewed and competitively awarded research on the science of opioid addiction.</text>
		</section></legis-body>
	<endorsement display="yes">
		<action-date display="yes">June 27, 2019</action-date>
		<action-desc>Committed to the Committee of the Whole House on the State of the Union and ordered to be printed</action-desc></endorsement>
</bill>


